Respiratorius
2,25 SEK
-13,46 %
RESP
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was established in 1999 as a spin-off from Lund University. The operations are located in Sweden, where research is conducted in-house, but also through international partners. The company has its headquarters in Lund.
Læs mereOmsætning og EBIT-margin
Omsætning
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
Delårsrapport Q1'26
Generalforsamling '26
Delårsrapport Q2'26
Respiratorius has conducted a pre-IND meeting with the FDA
Respiratorius Granted Pre-IND Meeting with FDA for VAL001
Bliv en del af Inderes community
Gå ikke glip af noget - opret en konto og få alle de mulige fordele